Hasil Pencarian - Umut Demirci

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Well differentiated neuroendocrine tumors, a single center experience

    Well differentiated neuroendocrine tumors, a single center experience oleh Ece Esin, Berna Oksuzoglu, Erkan Erdur, Guliz Ozgun, Umut Demirci

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    First line modified Folfirinox versus gemcitabine for advanced pancreatic cancer: A single institution retrospective experience

    First line modified Folfirinox versus gemcitabine for advanced pancreatic cancer: A single institution retrospective experience oleh Emrah Eraslan, Fatih Yildiz, Gulnihal Tufan, Ferit Aslan, Umut Demirci, Omur Berna Oksuzoglu

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Cetuximab Concomitant with Second-Line Radiation Therapy in Patients with Locally Advanced Recurrent Squamous Cell Head and Neck Cancer

    Cetuximab Concomitant with Second-Line Radiation Therapy in Patients with Locally Advanced Recurrent Squamous Cell Head and Neck Cancer oleh Muge Akmansu, Suleyman Buyukberber, Sevilay Iren, Umut Demirci, Gul Kanyilmaz, Ugur Coskun, Huseyin Bora

    Diterbitkan 2010-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Controversies in the efficacy of adjuvant chemotherapy in different epithelial ovarian carcinoma histologies

    Controversies in the efficacy of adjuvant chemotherapy in different epithelial ovarian carcinoma histologies oleh Ece Esin, İrem Bilgetekin, Fatma Buğdaycı Başal, Ayşe Ocak Duran, Umut Demirci, Berna Öksüzoğlu

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Short term real world safety data of pertuzumab use in HER2 targeted treatment of metastatic breast cancer

    Short term real world safety data of pertuzumab use in HER2 targeted treatment of metastatic breast cancer oleh Ece Esin, Omur Berna Cakmak Oksuzoglu, Erkan Erdur, Ozgen Ahmet Yildirim, Guliz Zengin, Aysegul Ilhan, Ulku Arslan, Umut Demirci

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Classic Kaposi's sarcoma: A review of 156 cases

    Classic Kaposi's sarcoma: A review of 156 cases oleh Bulent Cetin, Bilge Aktas, Oznur Bal, Efnan Algin, Tulay Akman, Lokman Koral, Mehmet Ali Kaplan, Umut Demirci, Dogan Uncu, Ahmet Ozet

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response

    Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response oleh Jeffrey S Ross, Karthikeyan Murugesan, Meagan Montesion, James Creeden, Lee A Albacker, Andrew D Kelly, Zheng Kuang, Richard S P Huang, Douglas I Lin, Umut Demirci

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer

    Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer oleh Ayşe Demirci, Cemil Bilir, Burcu Gülbağcı, İlhan Hacıbekiroğlu, İbrahim V. Bayoğlu, İrem Bilgetekin, Sinan Koca, Havva Y. Çınkır, Nadiye Akdeniz, Deniz Gül, Ceyhun Varım, Umut Demirci, Berna Öksüzoğlu

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study

    The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study oleh Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kilickap

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients

    Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treate... oleh Nuri Karadurmus, Mehmet Ali Nahit Sendur, Burcak Karaca, Omer Fatih Olmez, Ilhan Hacibekiroglu, Hasan Senol Coskun, Serkan Degirmencioglu, Yasemin Kemal, Saadettin Kilickap, Ahmet Taner Sumbul, Burc Aydin, Hande Turna, Muhammet Ali Kaplan, Nalan Babacan, Umut Demirci, Alper Ata, Dilek Erdem, Ahmet Ozet, Huseyin Abali

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: